BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 15, 2025
See today's BioWorld Asia
Home
» Other news to note for Sept. 22, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for Sept. 22, 2020
Sep. 22, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abound, Alaxia, Amgen, Axon, Betterlife, Biontech, Bristol Myers Squibb, C3.ai, Cebina, Cend, Dr. Reddy’s, Dyadic International, Eisai, Eli Lilly, Emergex, Eyevance, Fosun, Foundation Medicine, Generex, Genexine, Hepion, Hoth, Humanigen, Immunoprecise, Impilo, Janone, Jiangsu Hengrui Medicine, Junshi, Kiadis, Lonza, Mabion, Melior, Mylan, Nanoviricides, Neurorx, Novartis, Novavax, Octimet, Panolos, Pfizer, Pharmajet, Raziel, Relief, Revive, Samsung Biologics, Santen, Shanghai Fosun, Takeda, Teva, Tianjin Juvestar, Tiziana Life Sciences, Tonix, Transcenta Biomedical (Shanghai), Ufovax, Vaxine, Wigen Biomedicine, Xbiotech, Yufan, Zymeworks.
BioWorld Asia
Briefs
Other news to note